logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Clinical Drug Investigation cover

Clinical Drug Investigation

IF2.7
Papers191
Citations2979
Journal Papers 178
Publication Date
delete
Retrospective Real-World Comparison of Adherence, Persistence, Health-Care Utilization, and Costs Among Biologics for Moderate-to-Severe Psoriasis in China
deleteClinical Drug Investigation
IF2.7
delete2026-08-13
delete0
PREAI
deleteXiaoning He; Xiaoyang Xu; Xingzhi Wang; Jing Wu
deleteShare
deleteSave
Efficacy and Safety of Ustekinumab Biosimilars in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-analysis
deleteClinical Drug Investigation
IF2.7
delete2026-08-12
delete0
PREAI
deleteMohsin Rashid; Awon Muhammad; Eeraj Saeed; Ali Akram Qureshi; Mohammad Maheer Mubashir; Mohammad Waqas bin Waheed; Muhammad Abdullah Yasin; Muhammad Abdullah; Ahsan Rashid; Zainab Zubair
deleteShare
deleteSave
Modeling Cancer Outcomes and Economic Impact of the Anti-PD-1/PD-L1 Immunotherapy in the Gulf: United Arab Emirates, Oman, and Kuwait
deleteClinical Drug Investigation
IF2.7
delete2026-08-12
delete0
deleteOAAI
deleteHumaid O. Al-Shamsi; Mohamed Farghaly; Ammar Abdaljalil; Abdulwahab Al-Tourah; Chana Saad; Youmna Bassil; Ghadah Albassam; Rami Nimer; Monika Naroz; Omar El-Badry; Rony Akel
deleteShare
deleteSave
Cost Effectiveness of Teriparatide for Postmenopausal Osteoporosis: A Systematic Review
deleteClinical Drug Investigation
IF2.7
delete2026-08-08
delete0
PREAI
deleteMohammad Alimoradnori; Ali Abutorabi; Mozhdeh Zabihiyeganeh; Jalal Arabloo; Reza Jahanghiri
deleteShare
deleteSave
Effect of Hepatic Impairment on the Pharmacokinetics of Single-Dose Viloxazine Extended-Release Capsules (Qelbree®) in Adults
deleteClinical Drug Investigation
IF2.7
delete2026-07-26
delete0
deleteOAAI
deleteZhao Wang; Toyin Adewole; Lilian W. Adeojo; Peibing Qin; Stefan Schwabe; Azmi Nasser
deleteShare
deleteSave
JAK Inhibitors in Inflammatory Skin Diseases: A 15,427-Patient Systematic Review and Meta-analysis of Clinical Trial and Real-World Outcomes
deleteClinical Drug Investigation
IF2.7
delete2026-07-14
delete0
PREAI
deleteNada Faheem Zayed; Khaled Seetan; Almu’atasim Khamees; Raghad Yousef Yassin; Saleh A. Ba-shammakh
deleteShare
deleteSave
Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report
deleteClinical Drug Investigation
IF2.7
delete2026-07-10
delete0
deleteOAAI
deleteIbrahim El-Serafi; Rui He; Ying Zhao; Jonas Mattsson; Moustapha Hassan
deleteShare
deleteSave
Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles
deleteClinical Drug Investigation
IF2.7
delete2026-07-06
delete0
deleteOAAI
deleteClaudia Carmassi; Christoph U. Correll; Javier de Diego-Adeliño; Antonio Vian-Lains; Ciro Oliveira; Alex Schneider-Pérez; Vikas Mohan Sharma
deleteShare
deleteSave
Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18–64 Years in Hong Kong: A Population-Based Cohort Study
deleteClinical Drug Investigation
IF2.7
delete2026-07-03
delete0
deleteOAAI
deleteGeorge N. Okoli; Yun Lin; Peng Wu; Benjamin J. Cowling
deleteShare
deleteSave
Assessing the Adverse Events of Roflumilast and Tapinarof Use in Pediatric and Young Adult Patients with Atopic Dermatitis: A Systematic Review
deleteClinical Drug Investigation
IF2.7
delete2026-07-03
delete0
PREAI
deleteAnya Ramsamooj; Bethany M. Joy; Dave D. Manguerra; Valerie A. Gerriets
deleteShare
deleteSave
Repurposing Antipsychotics in Cancer Therapy: Modulation of Autophagy Mechanisms
deleteClinical Drug Investigation
IF2.7
delete2026-07-02
delete0
PREAI
deleteElahe Orak Sarkani; Sarvenaz Parsa; Sanaz Darash; Zahra Monzavi Chaleshtori; Motahareh Taghizadeh; Sheida Yahyazadeh; Omid Vakili
deleteShare
deleteSave
Deuruxolitinib: New Approval
deleteClinical Drug Investigation
IF2.7
delete2026-07-01
delete0
PREAI
deleteSimon Fung
deleteShare
deleteSave
Efficacy, Safety, Quality of Life, and Adherence of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review
deleteClinical Drug Investigation
IF2.7
delete2026-06-29
delete0
PREAI
deleteJacob Surma; Jenna Currier; David Doyle; Mackenzy Maddock; Garrett Borgman; Cassandra DeGroat; Sierra Demarinis; Natalie Aguilar; Spencer Williams; Patrick Fakhoury; Robert Stachler
deleteShare
deleteSave
Optimizing Amiodarone Maintenance Dose to Minimize N-Desethylamiodarone Accumulation and Pulmonary Toxicity: Insights from Machine Learning and Pharmacokinetic Simulation
deleteClinical Drug Investigation
IF2.7
delete2026-06-22
delete0
PREAI
deleteMinori Teraguchi; Toshiaki Komatsu; Yuto Akamada; Takeru Nabeta; Hidehira Fukaya; Junya Ako; Katsuya Otori
deleteShare
deleteSave
Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants
deleteClinical Drug Investigation
IF2.7
delete2026-06-19
delete0
deleteOAAI
deleteEva-Maria Sunzel; Giulia Ghibellini; Maria Gutierrez; Debra Ruffo; Shailendra Chavan; Nagnath G. Birajdar; Frank Schneider; Pippa Loupe; Mark Forrest Gordon; Laura Rabinovich-Guilatt
deleteShare
deleteSave
Ketamine and Evolving Neuroplasticity
deleteClinical Drug Investigation
IF2.7
delete2026-06-13
delete0
PREAI
deleteAngel Prabakar
deleteShare
deleteSave
Amyloid-Related Imaging Abnormalities in Anti-amyloid Therapy: Clinical Implications of Kinetics for Safer Use and Risk Stratification
deleteClinical Drug Investigation
IF2.7
delete2026-06-12
delete0
PREAI
deleteOzlem Totuk
deleteShare
deleteSave
Change in Adherence to Oral Antidiabetic Medications Before and After Prostate Cancer Diagnosis: A Group-Based Trajectory Modeling Approach
deleteClinical Drug Investigation
IF2.7
delete2026-06-10
delete0
deleteOAAI
deleteAhmed S. Kenawy; James O. Baffoe; Chanhyun Park
deleteShare
deleteSave
Modeling the Budget Impact of Disease-Modifying Therapies in Infantile-Onset Spinal Muscular Atrophy
deleteClinical Drug Investigation
IF2.7
delete2026-06-08
delete0
deleteOAAI
deleteSumaya Abuloha; Amie Goodin; Tianze Jiao; Manuela Corti; Mikael Svensson
deleteShare
deleteSave
Pigmentary Changes Reported with Tyrosine Kinase Inhibitors: A Narrative Review of Mechanisms and Clinical Implications
deleteClinical Drug Investigation
IF2.7
delete2026-06-08
delete0
PREAI
deleteMohammadsalman Parsapour; Navid Omidkhoda; Amir Hooshang Mohammadpour; Omid Arasteh
deleteShare
deleteSave